Menu

Fibrinogen (FG): A Central Player in Hemostasis

Endocrinology Diagnostics

Introduction

  • Fibrinogen (Factor I) is produced by the liver and is essential for blood clot formation.
  • Important for diagnosing and managing bleeding and clotting disorders.

Structure and Function

  • Composed of three pairs of chains (Aα, Bβ, γ).
  • Forms fibrin for blood clotting and aids in wound healing.
  • Promotes platelet aggregation and inflammatory cell influx.

Regulation of Fibrinogen Levels

  • Normal levels: 200-400 mg/dL.
  • Produced more during inflammation (acute phase protein), stimulated by IL-6.
  • Estrogen increases fibrinogen, while testosterone inhibits it.
  • Liver dysfunction can lower fibrinogen, causing bleeding issues.
  • Genetic mutations can cause afibrinogenemia or dysfibrinogenemia.

Clinical Significance of Fibrinogen

  • Bleeding Disorders: Low or dysfunctional fibrinogen leads to bleeding problems (e.g., afibrinogenemia).
  • Thrombotic Disorders: High fibrinogen increases clotting risks (e.g., DVT, PE) and is linked to inflammation and metabolic issues.
  • As a Biomarker: Elevated fibrinogen indicates inflammation and may predict heart disease, cancer, and clotting risks.

Suitable ELISA Kits

Visit the BioSupply Ltd website for more information on Fibrinogen (FG): A Central Player in Hemostasis

ENQUIRY FORM

More News

  • IL-17F: The Double-Edged Sword of Immune Defence and Inflammatory Disease

  • Immunoglobulin J Chain: The Essential Linker in Mucosal Immunity and Polymeric Antibody Formation

  • IDO1: The Metabolic Gatekeeper of Immune Regulation and Its Therapeutic Promise

  • Glucosylceramidase (GBA): The Cellular Recycler at the Crossroads of Lysosomal Health and Neurodegenerative Disease